Bolivia (Plurinational State of) vs Trinidad and Tobago: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology

Bolivia (Plurinational State of)
0.1%
in 2024
Trinidad and Tobago
0.1%
in 2024
Bolivia (Plurinational State of) rank
134th
Trinidad and Tobago rank
134th

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time

  • Bolivia (Plurinational State of)
  • Trinidad and Tobago
00.050.10.150.2201520192024

How they compare

Bolivia (Plurinational State of) currently reports 0.1% against 0.1% in Trinidad and Tobago, a difference of 0.0%.

Across all 10 years both countries report, Trinidad and Tobago has been ahead every year.

Bolivia (Plurinational State of) ranks 134th and Trinidad and Tobago ranks 134th of 246 countries.

Trinidad and Tobago has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Bolivia (Plurinational State of) Trinidad and Tobago Difference Ahead
2010s 0.0% 0.2% 0.2% Trinidad and Tobago
2020s 0.1% 0.1% 0.0% Trinidad and Tobago

Averages of every year both report within each decade.

Frequently asked questions

Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Bolivia (Plurinational State of) or Trinidad and Tobago?
Bolivia (Plurinational State of), at 0.1% against 0.1% in Trinidad and Tobago as of 2024.
What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Bolivia (Plurinational State of) and Trinidad and Tobago?
0.0%, with Bolivia (Plurinational State of) ahead.
How many years of comparable data are there for Bolivia (Plurinational State of) and Trinidad and Tobago?
10 years are reported by both, from 2015 to 2024.
How do Bolivia (Plurinational State of) and Trinidad and Tobago rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
Bolivia (Plurinational State of) ranks 134th and Trinidad and Tobago ranks 134th of 246 countries.
Where does this data come from?
United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Bolivia (Plurinational State of) vs Trinidad and Tobago: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 14 September 2026, from https://development-goals.statizoid.com/compare/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/bolivia-plurinational-state-of/trinidad-and-tobago/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://development-goals.statizoid.com/compare/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/bolivia-plurinational-state-of/trinidad-and-tobago/">Bolivia (Plurinational State of) vs Trinidad and Tobago: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology</a> — Statizoid

About this data

Indicator
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%)
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
250 places, 2,500 data points, 2015–2024
Last refreshed